A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

NCT04407234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity
Diabetes Mellitus, Type 2

Interventions

DRUG: Tirzepatide
DRUG: Acetaminophen

Sponsor

Eli Lilly and Company